PT70951A - Process for preparing new peptides - Google Patents

Process for preparing new peptides

Info

Publication number
PT70951A
PT70951A PT70951A PT7095180A PT70951A PT 70951 A PT70951 A PT 70951A PT 70951 A PT70951 A PT 70951A PT 7095180 A PT7095180 A PT 7095180A PT 70951 A PT70951 A PT 70951A
Authority
PT
Portugal
Prior art keywords
somatostatin
radical
trp
antagonistic
preparing new
Prior art date
Application number
PT70951A
Other languages
English (en)
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of PT70951A publication Critical patent/PT70951A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/655—Somatostatins
    • C07K14/6555—Somatostatins at least 1 amino acid in D-form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/06—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents
    • C07K1/061—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents using protecting groups
    • C07K1/065—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents using protecting groups for hydroxy functions, not being part of carboxy functions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/16—Somatostatin; related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PT70951A 1979-03-16 1980-03-14 Process for preparing new peptides PT70951A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH250679 1979-03-16

Publications (1)

Publication Number Publication Date
PT70951A true PT70951A (en) 1980-04-01

Family

ID=4235326

Family Applications (1)

Application Number Title Priority Date Filing Date
PT70951A PT70951A (en) 1979-03-16 1980-03-14 Process for preparing new peptides

Country Status (17)

Country Link
US (1) US4316890A (pt)
EP (1) EP0017760B1 (pt)
JP (1) JPS55124748A (pt)
KR (1) KR830001872A (pt)
AT (1) ATE3283T1 (pt)
AU (1) AU5646280A (pt)
CA (1) CA1140117A (pt)
DD (1) DD151059A5 (pt)
DE (1) DE3063028D1 (pt)
ES (1) ES489565A0 (pt)
FI (1) FI800795A (pt)
GR (1) GR67655B (pt)
IL (1) IL59620A (pt)
NO (1) NO800743L (pt)
NZ (1) NZ193129A (pt)
PT (1) PT70951A (pt)
ZA (1) ZA801520B (pt)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4499079A (en) * 1982-11-18 1985-02-12 E. R. Squibb & Sons, Inc. Carboxy and substituted carboxy alkanoyl and cycloalkanoyl peptides
US4612302A (en) * 1983-11-14 1986-09-16 Brigham And Women's Hospital Clinical use of somatostatin analogues
US5504069A (en) * 1993-02-11 1996-04-02 Biomeasure, Inc. Inhibition of trauma-induced tumor growth
US5965698A (en) * 1993-04-23 1999-10-12 Virginia Commonwealth University Polypeptides that include conformation-constraining groups which flank a protein--protein interaction site
US5928896A (en) * 1993-04-23 1999-07-27 Virginia Commonwealth University Polypeptides that include conformation-constraining groups which flank a protein--protein interaction site
US5952465A (en) * 1993-04-23 1999-09-14 Virginia Commonwealth University Polypeptides that include conformation-constraining groups which flank a protein-protein interaction site
WO1994025482A1 (en) * 1993-04-23 1994-11-10 Evans Herbert J Polypeptides that include conformation-constraining groups which flank a protein-protein interaction site
US6258550B1 (en) 1993-04-23 2001-07-10 Virginia Commonwealth University Polypeptides that include conformation-constraining groups which flank a protein-protein interaction site
US6084066A (en) * 1993-10-29 2000-07-04 Virginia Commonwealth University Polypetides that include conformation-constraining groups which flank a protein-protein interaction site
US5597894A (en) * 1995-06-05 1997-01-28 The Louisiana State University Medical Center Foundation Multi-tyrosinated somatostatin analogs
EP0981364B1 (en) * 1997-05-13 2006-03-01 Societe De Conseils De Recherches Et D'applications Scientifiques S.A.S. Method and compositions for treating hyperlipidemia
US6004928A (en) * 1997-05-13 1999-12-21 Biomeasure, Incorporated Method of treating hyperlipidemia
ES2216290T3 (es) * 1997-05-13 2004-10-16 Societe De Conseils De Recherches Et D'applications Scientifiques S.A.S. Somatostatina y agonistas de la somatostatina para el tratamiento de insensibilidad a la insulina y de sindrome x.
AU7655098A (en) 1997-05-13 1998-12-08 Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) Somatostatin and somatostatin agonists for decreasing body weight
US5968903A (en) * 1998-05-07 1999-10-19 Biomeasure, Incorporated Inhibition of H. pylori proliferation
PT2062914E (pt) 2001-06-08 2014-07-18 Ipsen Pharma Sas Análogos quiméricos de somatostatina-dopamina
EP2161037A3 (en) 2003-04-22 2010-05-26 Ipsen Pharma Camptothecin-Somatostatin conjugates
US20110171191A1 (en) 2008-06-12 2011-07-14 Syntaxin Limited Suppression of neuroendocrine diseases
US10240138B2 (en) 2008-06-12 2019-03-26 Ipsen Bioinnovation Limited Polypeptides that bind to and inhibit secretion from growth hormone secreting cells
GB0820970D0 (en) 2008-11-17 2008-12-24 Syntaxin Ltd Suppression of cancer
JP6869720B2 (ja) 2013-06-13 2021-05-12 アンチセンス セラピューティクス リミテッド 併用療法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4020157A (en) * 1975-07-08 1977-04-26 Ayerst Mckenna And Harrison Ltd. Shortened analogs of somatostatin
US4372884A (en) * 1975-08-06 1983-02-08 The Salk Institute For Biological Studies Pharmaceutically active peptides
NL7607987A (nl) * 1975-08-08 1977-02-10 Merck & Co Inc Werkwijze voor het bereiden van peptiden.
US4122077A (en) * 1976-12-17 1978-10-24 American Home Products Corporation Somatostatin analogs
US4098782A (en) * 1977-03-14 1978-07-04 American Home Products Corporation (His5)-somatostatin and analogues thereof
US4115554A (en) * 1977-08-29 1978-09-19 Merck & Co., Inc. Somatostatin analogs
GB2019411B (en) * 1978-04-24 1982-06-16 American Home Prod Peptides related to somatostatin

Also Published As

Publication number Publication date
NZ193129A (en) 1982-06-29
DE3063028D1 (en) 1983-06-16
IL59620A0 (en) 1980-06-30
CA1140117A (en) 1983-01-25
ZA801520B (en) 1981-03-25
ES8103028A1 (es) 1981-02-16
FI800795A (fi) 1980-09-17
AU5646280A (en) 1980-09-18
JPS55124748A (en) 1980-09-26
ATE3283T1 (de) 1983-05-15
US4316890A (en) 1982-02-23
DD151059A5 (de) 1981-09-30
NO800743L (no) 1980-09-17
ES489565A0 (es) 1981-02-16
IL59620A (en) 1983-07-31
EP0017760B1 (de) 1983-05-11
KR830001872A (ko) 1983-05-19
EP0017760A1 (de) 1980-10-29
GR67655B (pt) 1981-09-02

Similar Documents

Publication Publication Date Title
PT70951A (en) Process for preparing new peptides
ES8104993A1 (es) Un procedimiento para preparar compuestos aromaticos susti- tuidos
ES8105698A1 (es) Procedimiento para la obtencion de octapeptidos ciclicos
ZA91918B (en) 17beta-substituted-4-aza-5alpha-androstan-3-one derivatives and process for their preparation
JPS5564587A (en) Pyrimidoo*6*11a**isoquinolinee44one compound and its manufacture
DE3880396D1 (de) Zur behandlung von neurodegenerativen erkrankungen verwendbare kynurensaeurederivate.
ES461987A3 (es) Procedimiento para la fabricacion de nuevos gona-4,9 (10) dienos.
DE3667059D1 (en) Benzodipyrroles, processes for their preparation and pharmaceutical compositions containing these compounds
NZ217007A (en) Peptide derivative which inhibits proteases, preparation and pharmaceutical composition
ES8103071A1 (es) Procedimiento de preparacion de nuevos derivados aminicos del benzotiazol
NO159171C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktivt 2-(1-piperazinyl)-4-fenylkinazolin.
AU3087292A (en) New non ionic iodized agents for x-ray contrasting, method for preparing them and galenical compositions containing them
NO164474C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive heksahydropyrrolo(2,1-a)isokinolin-derivater.
GB2021588A (en) Bibenzyl Derivatives, the Preparation thereof and Pharmaceutical Compositions Containing them
HUT40110A (en) Process for preparing indole derivatives
ES528460A0 (es) Procedimiento de preparacion de nuevos deridados de alfa-etibenzol con un grupo amino propanolico sustituido y sus sales de adicion acidas y amonicas cuaternarias.
ES484086A1 (es) Procedimiento para la preparacion de compuestos de isopropi-lamina